BAX vs RGEN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

BAX

35.1
AI Score
VS
RGEN Wins

RGEN

45.4
AI Score

Investment Advisor Scores

BAX

35score
Recommendation
SELL

RGEN

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BAX RGEN Winner
Forward P/E 12.1507 61.3497 BAX
PEG Ratio 36.6767 1.6799 RGEN
Revenue Growth 5.3% 11.9% RGEN
Earnings Growth 36.8% -65.9% BAX
Tradestie Score 35.1/100 45.4/100 RGEN
Profit Margin -9.3% 5.3% RGEN
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD RGEN

Relative Price Performance (Last 90 Days)

BAX 1M: -11.7% · 3M: +16.2% RGEN 1M: -0.3% · 3M: +23.9%

Current Technical Phase

BAX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 35.1 · Price: $23.80

RGEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.7 · Price: $165.18

Fundamentals Snapshot

Metric BAX RGEN
Market Cap
Forward P/E 11.7 62.3
Trailing P/E 228.7
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.3% 0.5%
Operating Margin 0.1% 0.1%
EPS -1.86 0.72
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, RGEN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.